Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Archives of Pathology & Laboratory Medicine

• Publication date

  2017-08-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.5858/arpa.2016-0489-RAPMID 28854347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas

  2017cited by this paper
• Immunocytochemistry for Claudin‐18 and Maspin in biliary brushing cytology increases the accuracy of diagnosing pancreatobiliary malignancies

  2017cited by this paper
• HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

  2017cited by this paper
• Immunotherapy for Colorectal Cancer

  2017cited by this paper
• Cytokeratin 17 Expression is Associated With Poor Prognosis in Gallbladder Adenocarcinoma

  2017cited by this paper
• Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas

  2016cited by this paper
• Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma

  2016cited by this paper
• HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

  2016cited by this paper
• Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma

  2016influential reference
• SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type

  2016cited by this paper
• Special AT‐rich sequence‐binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high‐grade primary bone sarcomas

  2016cited by this paper
• Gastrointestinal tract spindle cell tumors with interstitial cells of Cajal: Prevalence excluding gastrointestinal stromal tumors

  2016influential reference
• CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

  2016cited by this paper
• Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.

  2016cited by this paper
• Arginase-1 is frequently positive in hepatoid adenocarcinomas.

  2016cited by this paper
• Immunotherapy with immunomodulatory antibody for hepatocellular carcinoma

  2016cited by this paper
• Correlation of Exon 3 β-catenin Mutations with Glutamine Synthetase Staining Patterns in Hepatocellular Adenoma and Hepatocellular Carcinoma

  2016cited by this paper
• Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT‐rich sequence‐binding protein 2 in their distinction from primary ovarian mucinous tumours

  2016cited by this paper
• Oncocytic variant of malignant gastrointestinal neuroectodermal tumor: a potential diagnostic pitfall.

  2016cited by this paper
• Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis.

  2016cited by this paper
• A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas

  2016cited by this paper
• Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.

  2016cited by this paper
• Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.

  2015cited by this paper
• SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.

  2015influential reference
• Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?

  2015cited by this paper
• HepPar-1 and Arginase-1 Immunohistochemistry in Adenocarcinoma of the Small Intestine and Ampullary Region.

  2015cited by this paper
• Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.

  2015cited by this paper
• Utility of immunohistochemistry in the pancreatobiliary tract.

  2015cited by this paper
• Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy.

  2015cited by this paper
• Clear cell sarcoma-like tumor of the gastrointestinal tract: an evolving entity.

  2015cited by this paper
• Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing

  2015cited by this paper
• Cadherin 17 is frequently expressed by ‘sclerosing variant’ pancreatic neuroendocrine tumour

  2015cited by this paper
• The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

  2015cited by this paper
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

  2015cited by this paper
• The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.

  2015cited by this paper
• Comparison of PAX6 and PAX8 as Immunohistochemical Markers for Pancreatic Neuroendocrine Tumors

  2015cited by this paper
• NKX6-1 Is a Novel Immunohistochemical Marker for Pancreatic and Duodenal Neuroendocrine Tumors

  2015influential reference
• VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer

  2015cited by this paper
• Branched Chain In Situ Hybridization for Albumin as a Marker of Hepatocellular Differentiation: Evaluation of Manual and Automated In Situ Hybridization Platforms

  2015influential reference
• Fibrolamellar carcinoma versus scirrhous hepatocellular carcinoma : diagnostic usefulness of CD68.

  2015cited by this paper
• Gene mutations in hepatocellular adenomas

  2015cited by this paper
• Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups

  2015cited by this paper
• The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.

  2015cited by this paper
• Expression of cadherin 17 in well‐differentiated neuroendocrine tumours

  2015cited by this paper
• Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance.

  2015cited by this paper
• Select biomarkers for tumors of the gastrointestinal tract: present and future.

  2015cited by this paper
• Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?

  2015cited by this paper
• Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder

  2015cited by this paper
• The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms

  2015cited by this paper
• Heterogenous MSH6 Loss Is a Result of Microsatellite Instability Within MSH6 and Occurs in Sporadic and Hereditary Colorectal and Endometrial Carcinomas

  2015cited by this paper
• Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction.

  2015cited by this paper
• Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.

  2014cited by this paper
• Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase

  2014cited by this paper
• Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics.

  2014cited by this paper
• Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.

  2014cited by this paper
• IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma.

  2014cited by this paper
• Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.

  2014cited by this paper
• Crohn enteritis-associated small bowel adenocarcinomas exhibit gastric differentiation.

  2014cited by this paper
• BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.

  2014cited by this paper
• Leiomyoma of the Gastrointestinal Tract With Interstitial Cells of Cajal: A Mimic of Gastrointestinal Stromal Tumor

  2014influential reference
• Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.

  2014cited by this paper
• Prospects for targeting PD-1 and PD-L1 in various tumor types.

  2014cited by this paper
• The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.

  2014cited by this paper
• The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater

  2014cited by this paper
• Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions

  2014cited by this paper
• Detection of the BRAF V600E Mutation in Colon Carcinoma: Critical Evaluation of the Imunohistochemical Approach

  2014cited by this paper
• Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma

  2014cited by this paper
• Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications.

  2014cited by this paper
• An intra-abdominal desmoid tumor difficult to distinguish from a gastrointestinal stromal tumor: report of two cases

  2014cited by this paper
• Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

  2014cited by this paper
• The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14‐3‐3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine‐needle aspiration

  2014cited by this paper
• Clusterin: a key player in cancer chemoresistance and its inhibition

  2014cited by this paper
• Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

  2014cited by this paper
• Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature

  2014influential reference
• Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum.

  2014influential reference
• Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine.

  2014influential reference
• Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.

  2013cited by this paper
• Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.

  2013cited by this paper
• The Immunohistochemical Expression of Islet 1 and PAX8 by Rectal Neuroendocrine Tumors Should Be Taken into Account in the Differential Diagnosis of Metastatic Neuroendocrine Tumors of Unknown Primary Origin

  2013influential reference
• Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.

  2013cited by this paper
• Gastrointestinal stromal tumors.

  2013cited by this paper
• Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma

  2013cited by this paper
• Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder.

  2013cited by this paper
• Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers

  2013cited by this paper
• Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.

  2013cited by this paper
• Beyond the GIST: mesenchymal tumors of the stomach.

  2013cited by this paper
• BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens

  2013cited by this paper
• Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.

  2013cited by this paper
• Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency

  2013cited by this paper
• Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours

  2013cited by this paper
• Assigning Site of Origin in Metastatic Neuroendocrine Neoplasms: A Clinically Significant Application of Diagnostic Immunohistochemistry

  2013cited by this paper
• Loss of CDX2/CK20 Expression Is Associated With Poorly Differentiated Carcinoma, the CpG Island Methylator Phenotype, and Adverse Prognosis in Microsatellite-unstable Colorectal Cancer

  2013cited by this paper
• Islet-1 Is a Sensitive But Not Entirely Specific Marker for Pancreatic Neuroendocrine Neoplasms and Their Metastases

  2013influential reference
• SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours

  2013cited by this paper
• Immunohistochemistry of colorectal carcinoma: current practice and evolving applications.

  2013influential reference
• Immunohistochemistry using the BRAF V600E mutation‐specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma

  2013cited by this paper
• Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.

  2013cited by this paper
• Clinicopathologic Study of 62 Acinar Cell Carcinomas of the Pancreas: Insights Into the Morphology and Immunophenotype and Search for Prognostic Markers

  2012cited by this paper

• Intraosseous tumours of the knee.

  2026cites this paper
• Clinicopathological significance of histological diversity in gastric adenocarcinoma with primitive enterocyte phenotype: A methylation-driven aggressive entity

  2025cites this paper
• A Practical Approach to the Diagnosis of Liver Metastases from Cancer of Unknown Primary: Application of Immunohistochemistry and an Update.

  2025cites this paper
• Immunohistochemistry as a diagnostic tool in pathology

  2025cites this paper
• Extrahepatic cholangiocarcinoma: Current concepts in histopathology, immunohistochemistry, and molecular diagnostics.

  2025cites this paper
• Consensus statements on endoscopic ultrasound‐guided tissue acquisition. Guidelines from the Asian Endoscopic Ultrasound Group

  2024cites this paper
• SH3 domain‑binding glutamic acid‑rich protein‑like 3 is associated with hyperglycemia and a poor outcome in Epstein‑Barr virus‑negative gastric carcinoma

  2024cites this paper
• Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma

  2024influential citation
• GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors

  2023cites this paper
• EASL-ILCA Clinical Practice Guidelines on Intrahepatic Cholangiocarcinoma.

  2023cites this paper
• Challenges in Diagnosing and Reporting Cholangiocarcinoma.

  2023cites this paper
• Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine.

  2023cites this paper
• Ancillary Tests for Hepatobiliary Neoplasms: What We Know and What We Need to Know.

  2023cites this paper
• Hepatocellular Carcinoma's Molecular Markers: The New Trend as Diagnostic/Prognostic Markers!

  2023cites this paper
• Current and Emerging Molecular Markers of Liver Diseases: A Pathogenic Perspective

  2022cites this paper
• Carcinoma of Unknown Primary Origin: Application of Immunohistochemistry With Emphasis to Different Cytokeratin 7 and 20 Staining Patterns

  2022cites this paper
• Immunocytochemistry for diagnostic cytopathology—A practical guide

  2021cites this paper
• Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

  2021cites this paper
• The Differential Diagnosis of Intrahepatic Ductular Reaction in Medical Liver Biopsy.

  2021cites this paper
• Differentiation of primary lung cancer from solitary lung metastasis in patients with colorectal cancer: a retrospective cohort study

  2021cites this paper
• Does ProCore Fine-Needle Biopsy Really Improve the Clinical Outcome of Endoscopic Ultrasound-Guided Sampling of Pancreatic Masses?

  2021cites this paper
• Metastatic gallbladder carcinoma presenting as an ovarian mass

  2021cites this paper
• Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study

  2021influential citation
• Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors

  2021influential citation
• An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy

  2021cites this paper
• Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate

  2021cites this paper
• Invasive adenocarcinoma of the extrahepatic bile ducts.

  2021cites this paper
• Synchronous small bowel and colonic tumours in the absence of Lynch syndrome

  2021cites this paper
• Invasive adenocarcinoma of the extrahepatic bile ducts.

  2021cites this paper
• Diagnostic value of clusterin immunostaining in hepatocellular carcinoma

  2020cites this paper
• SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins.

  2020cites this paper
• Endometrial clear cell carcinoma with metastasis to the common hepatic duct: A rare aetiology of obstructive jaundice, diagnosed by biliary cytology brushing specimen

  2020cites this paper
• Appendiceal Diseases

  2020cites this paper
• Syndromic Epithelial Polyps of the Gastrointestinal Tract

  2020cites this paper
• Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine

  2020cites this paper
• Carcinomas of the Gastrointestinal Tract

  2020cites this paper
• Immunostains: Solid Tumors

  2019cites this paper
• New and Emerging Biomarkers in Endocrine Pathology

  2019cites this paper
• Oncosuppressor-Mutated Cells as a Liquid Biopsy Test for Cancer-Screening

  2019cites this paper
• Acinar Cell Carcinoma (ACC) in a Patient with Hypoglycemia: A Case Report

  2019cites this paper
• Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers

  2019cites this paper
• Ancillary tests in the diagnosis of liver and pancreatic neoplasms

  2018cites this paper
• Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

  2018influential citation
• CLINICAL AND PATHOLOGICAL FACTORS OF PROGNOSIS AFTER HEPATECTOMY FOR GASTRIC CANCER LIVER METASTASES

  2018cites this paper
• Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma.

  2018cites this paper
• [Carcinoma of unknown primary. Case no. 3].

  2018cites this paper